Effect of first-line spartalizumab + dabrafenib + trametinib on immunosuppressive features detected in peripheral blood and clinical outcome in patients (pts) with advanced BRAF V600–mutant melanoma
Saved in:
Published in | Journal of Clinical Oncology Vol. 38; p. 10034 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | Japanese |
Published |
American Society of Clinical Oncology (ASCO)
20.05.2020
|
Subjects | |
Online Access | Get full text |
ISSN | 0732-183X 1527-7755 |
DOI | 10.1200/jco.2020.38.15_suppl.10034 |
Cover
Loading…
Author | Tawbi, Hussein Abdul-Hassan Robert, Caroline Ramesh, Radha Ribas, Antoni Gusenleitner, Daniel Richtig, Erika Flaherty, Keith Dummer, Reinhard Arance, Ana Gasal, Eduard Biette, Kelly Yamazaki, Naoya Brase, Jan C. Ascierto, Paolo Antonio Atkinson, Victoria Mandalà, Mario Nathan, Paul D. Schadendorf, Dirk Lebbe, Celeste Long, Georgina V. |
---|---|
Author_xml | – sequence: 1 fullname: Dummer, Reinhard – sequence: 2 fullname: Biette, Kelly – sequence: 3 fullname: Gusenleitner, Daniel – sequence: 4 fullname: Ramesh, Radha – sequence: 5 fullname: Lebbe, Celeste – sequence: 6 fullname: Atkinson, Victoria – sequence: 7 fullname: Mandalà, Mario – sequence: 8 fullname: Nathan, Paul D. – sequence: 9 fullname: Arance, Ana – sequence: 10 fullname: Richtig, Erika – sequence: 11 fullname: Yamazaki, Naoya – sequence: 12 fullname: Robert, Caroline – sequence: 13 fullname: Schadendorf, Dirk – sequence: 14 fullname: Tawbi, Hussein Abdul-Hassan – sequence: 15 fullname: Ascierto, Paolo Antonio – sequence: 16 fullname: Ribas, Antoni – sequence: 17 fullname: Flaherty, Keith – sequence: 18 fullname: Gasal, Eduard – sequence: 19 fullname: Brase, Jan C. – sequence: 20 fullname: Long, Georgina V. |
BackLink | https://cir.nii.ac.jp/crid/1873116917469384960$$DView record in CiNii |
BookMark | eNotjdFq1kAQhRep4G_tOwzihSKJs7tJdnNZS6tCQZAi3pXJ7izdkuyGZFOhV76DL-Vz-CTmV29m-A6H7zwXJyknFuKlxFoqxHf3LtcKFdba1rK9Xbd5HmuJqJsn4iBbZSpj2vZEHNBoVUmrvz0TZ-saB2x1Z5XWeBC_LkNgVyAHCHFZSzXGxLDOtBQa4-M20QBvwdOwUOAUj1AWmrjEI-QEcZq2lI_bC-_uB4bAVLYdwHPZ1ewhJph5ifMdLzTCMObsgZIHt49Ft0d5Ky5P_LdIJXIqK7yey_oGvsdyB-QfKLld9P7L-RV87RB___g5bYVSgYlHSnmiF-JpoHHls___VNxcXd5cfKyuP3_4dHF-Xd33LVaSOCjjlWYdmsGgZdnpxhmzJ12rtG96L307DEGTocaya4gkK0u9Q2NRn4pX_7QpxlsXj1dao6Xsemmarte26TvUfwAWLIJk |
ContentType | Journal Article |
DBID | RYH |
DOI | 10.1200/jco.2020.38.15_suppl.10034 |
DatabaseName | CiNii Complete |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1527-7755 |
EndPage | 10034 |
GroupedDBID | --- .55 0R~ 18M 2WC 34G 39C 4.4 53G 5GY 5RE 8F7 AAQQT AARDX AAWTL AAYEP ABBLC ABJNI ABOCM ACGFO ACGFS ACGUR ADBBV AEGXH AENEX AIAGR ALMA_UNASSIGNED_HOLDINGS BAWUL BYPQX C45 CS3 DIK EBS EJD F5P F9R FBNNL FD8 GX1 H13 HZ~ IH2 K-O KQ8 L7B LSO MJL N9A O9- OK1 OVD OWW P2P QTD R1G RHI RLZ RUC RYH SJN TEORI TR2 TWZ UDS VVN WH7 X7M YFH YQY |
ID | FETCH-LOGICAL-j950-1aef27d23e3f4b708e1634c7723e6523d49d1d5bbf3a7a48ec4aa1e28a9c07803 |
ISSN | 0732-183X |
IngestDate | Thu Jun 26 23:04:28 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j950-1aef27d23e3f4b708e1634c7723e6523d49d1d5bbf3a7a48ec4aa1e28a9c07803 |
PageCount | 1 |
ParticipantIDs | nii_cinii_1873116917469384960 |
PublicationCentury | 2000 |
PublicationDate | 2020-05-20 |
PublicationDateYYYYMMDD | 2020-05-20 |
PublicationDate_xml | – month: 05 year: 2020 text: 2020-05-20 day: 20 |
PublicationDecade | 2020 |
PublicationTitle | Journal of Clinical Oncology |
PublicationYear | 2020 |
Publisher | American Society of Clinical Oncology (ASCO) |
Publisher_xml | – name: American Society of Clinical Oncology (ASCO) |
SSID | ssib053682330 ssib002812892 ssib050995433 ssib058493172 ssib055817461 ssib002151296 ssib002574276 ssib008075819 ssib000428817 ssj0014835 ssib004908933 ssib020737366 ssib002836462 |
Score | 2.4273865 |
SourceID | nii |
SourceType | Publisher |
StartPage | 10034 |
SubjectTerms | Medizin |
Title | Effect of first-line spartalizumab + dabrafenib + trametinib on immunosuppressive features detected in peripheral blood and clinical outcome in patients (pts) with advanced BRAF V600–mutant melanoma |
URI | https://cir.nii.ac.jp/crid/1873116917469384960 |
Volume | 38 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtNAFB21RULdICggXkV3gSpQ6mDP-LlsC1WFVFqVgLKrxvZYdZQ4FbEX7Yp_4Kf4Dr6EO6-OoxTx2FixY-cxd87MuXPvPUPIK5yCkqhIhVeUAffCmFdezgp0VnC2LOIyR5IslwaOP8ZHn8MP42i8tr7Zy1rq2nxYXN9aV_I_VsVraFdZJfsPlr35ULyAr9G-eEQL4_GvbGykh5HvVTWyOE9RRhwiJKOur7sZz9Gy-4OSo0tciabWp63Mx2preSrzHGWByHzRXeqMWCkCLpTY52JQChlhEKXONMfRRdZqTXWuu66Hs2WV867F_6f0R4xQq1rMvZQ5Gpmpn7PJBvtne4eDL8iAbJ4Fm3VyK-PBTEx5MzfzxCpfPrBfdtIUS7GAd93MbAFzJurGygTolX-ZyKTLj6a9vFW57DQVdWuKfXSZvYt4zcRCLTad8fKC95dFqIroU991ZBvvssmvt_1O2RJ7nw5O7KKLHnYTRj0c6MZ6hjTTAk3QD9GCwnbe0Ko0ZuAPpNBPj0XcnK9MUVTtvj0pZOUp9YcsHQbRubTydKgeWid3KLo8ahuScT9CS9O071orqtZ3DZOQJv2IOTKPpYg5i8OeNKQK-PaovhSlTp20H8VmSJij-sgrsyh090csTilzrmeEDyc9aULktRlS0xspN_S69Wa3tnWNADC2xtvftwUSvqaue4RvdJ_cMz0P9jTsHpC1Cd8id49NLsoW2TnVqu9XuzByRYyLXdiBU6cHf_WQ_NAwhXkFDqawBFMYgAMpnjiIwryBFYiChShYiELdgIMoKIgCQhQsRMFAVN1oIAqvEaBvQMITLDxBwhMkPH9--66BCRaYj8jo8P3o4MgzG6h4kyzyvYCLiiYlZYJVYZ74qUDnKyywczERR5SVYVYGZZTnFeMJD1NRhJwHgqY8K9Bz8NljstHMG_GEQMpFGBQi8Cs_D_OccnR7SsHTimc0KUr_KdlGQ51j--MxSBMWSBEu7BAZw44Q-8_-8P5zsulA_IJstF87sY1sv81fKhj8AksV72w |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+first-line+spartalizumab+%2B+dabrafenib+%2B+trametinib+on+immunosuppressive+features+detected+in+peripheral+blood+and+clinical+outcome+in+patients+%28pts%29+with+advanced+BRAF+V600%E2%80%93mutant+melanoma&rft.jtitle=Journal+of+Clinical+Oncology&rft.au=Dummer%2C+Reinhard&rft.au=Biette%2C+Kelly&rft.au=Gusenleitner%2C+Daniel&rft.au=Ramesh%2C+Radha&rft.date=2020-05-20&rft.pub=American+Society+of+Clinical+Oncology+%28ASCO%29&rft.issn=0732-183X&rft.eissn=1527-7755&rft.volume=38&rft.spage=10034&rft.epage=10034&rft_id=info:doi/10.1200%2Fjco.2020.38.15_suppl.10034 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0732-183X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0732-183X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0732-183X&client=summon |